The overall results of the SPARTA system is shown in Figure 7A. Liu et al. [75] demonstrated that isolated microvesicles are more effective than exosomes and apoptotic bodies in differentiating breast cell lines and Stage II breast cancer patients with varying immune histochemical expression of HER2. This evidence concerns the gene ERBB2 and breast carcinoma.